A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478612/
https://www.ncbi.nlm.nih.gov/pubmed/32899104
http://dx.doi.org/10.1097/MD.0000000000022168
_version_ 1783580091049050112
collection PubMed
description
format Online
Article
Text
id pubmed-7478612
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74786122020-09-24 A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum Medicine (Baltimore) Erratum Lippincott Williams & Wilkins 2020-09-04 /pmc/articles/PMC7478612/ /pubmed/32899104 http://dx.doi.org/10.1097/MD.0000000000022168 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Erratum
A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum
title A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum
title_full A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum
title_fullStr A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum
title_full_unstemmed A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum
title_short A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum
title_sort phase 3 double-blind randomized (consort-compliant) study of azilsartan medoxomil compared to valsartan in chinese patients with essential hypertension: erratum
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478612/
https://www.ncbi.nlm.nih.gov/pubmed/32899104
http://dx.doi.org/10.1097/MD.0000000000022168

Ejemplares similares